Peripheral artery disease affects up to 12% of the U.S. population, but is often under-diagnosed and inadequately treated. ... Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease.
https://acpinternist.org/weekly/archives/2021/04/13/6.htm. A randomized trial found that patients with peripheral artery disease (PAD) assigned to high-intensity walking significantly improved their distances on ... Six-minute walking distance did not
Peripheral artery disease (PAD) has a bigger public health impact than many better known coronary vascular diseases, but awareness of symptoms and interventions lag behind, an expert said. ... The technologies for screening, diagnosing and caring for
https://acpinternist.org/weekly/archives/2022/04/19/2.htm. The randomized trial, which connected patients with intermittent claudication due to peripheral artery disease (PAD) with physical therapists, found an increase ... A home-based, walking exercise
to reduce risk of heart attack, stroke, cardiovascular death, and need for revascularization in patients with a previous heart attack or peripheral artery disease. ... Vorapaxar (Zontivity) to reduce the risk of heart attack, stroke, cardiovascular death,
After stroke, health care professionals and stroke survivors tend to focus most of their rehabilitation on recovery, but the prevention of a subsequent stroke, as well as CAD and peripheral artery ... disease, is also an important task,” the authors
https://acpinternist.org/archives/2011/04/editors.htm. Peripheral artery disease is a common, and significant, problem estimated to affect up to 12% of people in the United States. ... Peripheral artery disease (PAD) is a common, and significant, problem
In the trials, patients at the highest risk for atherosclerotic cardiovascular disease events (acute coronary syndrome, myocardial infarction, stroke, angina, peripheral artery disease, or coronary revascularization) gained the most benefit from
It was approved based on data from the ADVANCE trial. The Zilver PTX stent, the first drug-eluting stent indicated to re-open the femoropopliteal artery when narrowed or blocked as ... a result of peripheral artery disease.
https://acpinternist.org/archives/2011/05/letter.htm. A reader responds about physical exams for PAD. The author of the fine article on peripheral artery disease (PAD) [“An easy screen for ... an overlooked disease,” ACP Internist, April 2011]